THE USE OF TUMOR NECROSIS FACTOR α INHIBITORS IN PATIENTS WITH WEBER-CHRISTIAN DISEASE

Weber-Christian disease (WCD), also known as idiopathic lobular panniculitis, is a rare disease belonging to the group of diffuse connective tissue diseases. No therapy for WCD has been developed; empirical treatment is typically used. The first description of the use of tumor necrosis factor α inhi...

Full description

Saved in:
Bibliographic Details
Main Authors: Olga Nikolayevna Egorova, B S Belov, S G RadenskaLopovok, O V Pushkova, N M Savushkina, Ya B Khrennikov, E L Nasonov
Format: Article
Language:Russian
Published: IMA PRESS LLC 2014-02-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/1686
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849688986462715904
author Olga Nikolayevna Egorova
B S Belov
S G RadenskaLopovok
O V Pushkova
N M Savushkina
Ya B Khrennikov
E L Nasonov
author_facet Olga Nikolayevna Egorova
B S Belov
S G RadenskaLopovok
O V Pushkova
N M Savushkina
Ya B Khrennikov
E L Nasonov
author_sort Olga Nikolayevna Egorova
collection DOAJ
description Weber-Christian disease (WCD), also known as idiopathic lobular panniculitis, is a rare disease belonging to the group of diffuse connective tissue diseases. No therapy for WCD has been developed; empirical treatment is typically used. The first description of the use of tumor necrosis factor α inhibitors in a female patient with infiltrative WCD is presented. The tactics of managing this patient category are analyzed.
format Article
id doaj-art-41c7c47385864fee9138cb096d19db0d
institution DOAJ
issn 1995-4484
1995-4492
language Russian
publishDate 2014-02-01
publisher IMA PRESS LLC
record_format Article
series Научно-практическая ревматология
spelling doaj-art-41c7c47385864fee9138cb096d19db0d2025-08-20T03:21:47ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922014-02-01516721410.14412/1995-4484-2013-721-41623THE USE OF TUMOR NECROSIS FACTOR α INHIBITORS IN PATIENTS WITH WEBER-CHRISTIAN DISEASEOlga Nikolayevna Egorova0B S Belov1S G RadenskaLopovok2O V Pushkova3N M Savushkina4Ya B Khrennikov5E L Nasonov6Nasonova Research Institute of Rheumatology, Russian Academy of Medical Sciences, Moscow, RussiaNasonova Research Institute of Rheumatology, Russian Academy of Medical Sciences, Moscow, RussiaNasonova Research Institute of Rheumatology, Russian Academy of Medical Sciences, Moscow, RussiaNasonova Research Institute of Rheumatology, Russian Academy of Medical Sciences, Moscow, RussiaNasonova Research Institute of Rheumatology, Russian Academy of Medical Sciences, Moscow, RussiaNasonova Research Institute of Rheumatology, Russian Academy of Medical Sciences, Moscow, RussiaNasonova Research Institute of Rheumatology, Russian Academy of Medical Sciences, Moscow, RussiaWeber-Christian disease (WCD), also known as idiopathic lobular panniculitis, is a rare disease belonging to the group of diffuse connective tissue diseases. No therapy for WCD has been developed; empirical treatment is typically used. The first description of the use of tumor necrosis factor α inhibitors in a female patient with infiltrative WCD is presented. The tactics of managing this patient category are analyzed.https://rsp.mediar-press.net/rsp/article/view/1686weber-christian diseaseidiopathic lobular panniculitisetanercept, adalimumab
spellingShingle Olga Nikolayevna Egorova
B S Belov
S G RadenskaLopovok
O V Pushkova
N M Savushkina
Ya B Khrennikov
E L Nasonov
THE USE OF TUMOR NECROSIS FACTOR α INHIBITORS IN PATIENTS WITH WEBER-CHRISTIAN DISEASE
Научно-практическая ревматология
weber-christian disease
idiopathic lobular panniculitis
etanercept, adalimumab
title THE USE OF TUMOR NECROSIS FACTOR α INHIBITORS IN PATIENTS WITH WEBER-CHRISTIAN DISEASE
title_full THE USE OF TUMOR NECROSIS FACTOR α INHIBITORS IN PATIENTS WITH WEBER-CHRISTIAN DISEASE
title_fullStr THE USE OF TUMOR NECROSIS FACTOR α INHIBITORS IN PATIENTS WITH WEBER-CHRISTIAN DISEASE
title_full_unstemmed THE USE OF TUMOR NECROSIS FACTOR α INHIBITORS IN PATIENTS WITH WEBER-CHRISTIAN DISEASE
title_short THE USE OF TUMOR NECROSIS FACTOR α INHIBITORS IN PATIENTS WITH WEBER-CHRISTIAN DISEASE
title_sort use of tumor necrosis factor α inhibitors in patients with weber christian disease
topic weber-christian disease
idiopathic lobular panniculitis
etanercept, adalimumab
url https://rsp.mediar-press.net/rsp/article/view/1686
work_keys_str_mv AT olganikolayevnaegorova theuseoftumornecrosisfactorainhibitorsinpatientswithweberchristiandisease
AT bsbelov theuseoftumornecrosisfactorainhibitorsinpatientswithweberchristiandisease
AT sgradenskalopovok theuseoftumornecrosisfactorainhibitorsinpatientswithweberchristiandisease
AT ovpushkova theuseoftumornecrosisfactorainhibitorsinpatientswithweberchristiandisease
AT nmsavushkina theuseoftumornecrosisfactorainhibitorsinpatientswithweberchristiandisease
AT yabkhrennikov theuseoftumornecrosisfactorainhibitorsinpatientswithweberchristiandisease
AT elnasonov theuseoftumornecrosisfactorainhibitorsinpatientswithweberchristiandisease
AT olganikolayevnaegorova useoftumornecrosisfactorainhibitorsinpatientswithweberchristiandisease
AT bsbelov useoftumornecrosisfactorainhibitorsinpatientswithweberchristiandisease
AT sgradenskalopovok useoftumornecrosisfactorainhibitorsinpatientswithweberchristiandisease
AT ovpushkova useoftumornecrosisfactorainhibitorsinpatientswithweberchristiandisease
AT nmsavushkina useoftumornecrosisfactorainhibitorsinpatientswithweberchristiandisease
AT yabkhrennikov useoftumornecrosisfactorainhibitorsinpatientswithweberchristiandisease
AT elnasonov useoftumornecrosisfactorainhibitorsinpatientswithweberchristiandisease